Furthermore, there was no significant correlation between TMPRSS2 expression and the prognosis of breast cancer in decreased CD4+ T cells (p = 0.094) and decreased CD8+ T cells (p = 0.24) (Figures 5B, D). This evidence concerns the gene TMPRSS2 and breast carcinoma.